NCT00115414View on ClinicalTrials.gov

Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC)

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Breast CancerFeverNeutropenia
Interventions
DRUG

pegfilgrastim

DRUG

docetaxel

DRUG

doxorubicin

DRUG

cyclophosphamide

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY

NCT00115414 - Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC) | Biotech Hunter | Biotech Hunter